Evidence map›Paper›PMID 39440979›Full record

ArticlemBio2024

Frédérique Vernel-Pauillac, Christine Laurent-Winter, Laurence Fiette, Guilhem Janbon, Vishukumar Aimanianda, Françoise Dromer

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Insights from Mass Spectrometry-Based Proteomics onJournal of fungi (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Frédérique Vernel-PauillacInstitut Pasteur, Université Paris Cité, CNRS, Molecular Mycology Unit, UMR 2000, Paris, France.
Christine Laurent-WinterInstitut Pasteur, Université Paris Cité, CNRS UAR 2024, Mass Spectrometry for Biology Unit, Proteomics platform, Paris, France.
Laurence FietteInstitut Pasteur, Human Histopathology and Animal Models Unit, Paris, France.
Guilhem JanbonInstitut Pasteur, Université Paris Cité, CNRS, Molecular Mycology Unit, UMR 2000, Paris, France.
Vishukumar AimaniandaInstitut Pasteur, Université Paris Cité, CNRS, Molecular Mycology Unit, UMR 2000, Paris, France.ORCID 0000-0001-5813-7497
Françoise DromerInstitut Pasteur, Université Paris Cité, CNRS, Molecular Mycology Unit, UMR 2000, Paris, France.ORCID 0000-0003-1671-1475

Funding

Institut Pasteur recurrent funding,Technology Transfer and Industrial Partnership DepartmentLabex IBEID IBEIDMerieux Foundation Merieux Research grant
6 · The paper itself

Abstract

Though a confined or a broad population is exposed respectively to endemic or pandemic infections, in the same environment, some individuals resist the development of infections. The attributed reason is the inheritance of a set of immune system genes that can efficiently deal with the pathogens. In this study, we show how outbred mice differentially respond to IMPORTANCE: Vaccination and immunotherapies against fungal pathogens still remain a challenge. Here, we show using an

Indexed as

Antibodies, FungalAspartic Acid ProteasesCryptococcosisCryptococcus neoformansFungal VaccinesAnimalsAntibodies, MonoclonalAntigens, FungalDisease Models, AnimalFemaleFungal ProteinsImmunization, PassiveMicePhagocytosisSurvival AnalysisVaccinationAntibodies, FungalAntibodies, MonoclonalAntigens, FungalAspartic Acid ProteasesFungal ProteinsFungal Vaccinesaspartic protease Pep1pCryptococcus neoformansmonoclonal antibodiespassive therapyprophylaxisvaccination

Identifiers

PMID39440979
PMCPMC11559057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.